Výsledky vyhledávání - "María Soledad Undurraga S"

Neutropenia febril de alto riesgo en leucemia aguda. Experiencia en un hospital público: Programa Nacional de Drogas Antineoplásicas del Adulto (PANDA), Hospital del Salvador, 1991-2001

Autor: Gonzalo Urrejola S, María Soledad Undurraga S, Ismael Puga R, Pilar Toro V, María Elena Cabrera C, Carolina Guerra C, Barbara Puga L

Publikováno v: Revista médica de Chile v.131 n.9 2003
SciELO Chile
CONICYT Chile
instacron:CONICYT

Febrile neutropenia is one of the most important problems to face during the treatment of acute leukemia. Aim: To assess the results of a standardized protocol for the treatment of febrile neutropenia and compare it with a period in which treatment w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa2bb9e5382038ad09f2dabf8044f1c
https://doi.org/10.4067/s0034-98872003000900008

Zobrazit plný text záznamu

Leucemia mieloide aguda del adulto: Resultados del Protocolo Nacional de Drogas Antineoplásica. Hospital del Salvador 1990-1998

Autor: María Elena Cabrera C, Barbara Puga L, Germán Ducach G, María Soledad Undurraga S, Humberto Toledo G, Ricardo Vacarezza Y, Raúl Etcheverry B

Publikováno v: Revista médica de Chile v.128 n.11 2000
SciELO Chile
CONICYT Chile
instacron:CONICYT

Background: The incidence of acute myeloid leukemia is 3 cases per 100.000 inhabitants/year and its five years event free survival is 15 to 20%. Since the incorporation of trans retinoic acid, event free survival of M3 acute myeloid leukemia is 80%.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f0be10e8ef834a0f81a112ab2416f1
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100002

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání